Shimonaka M, Yamaguchi Y
Cancer Research Center, La Jolla Cancer Research Foundation, California 92037.
J Biol Chem. 1994 May 13;269(19):14284-9.
We have identified a motility factor in conditioned medium of human fibroblasts that stimulates the migration of HepG2 cells in the Boyden chamber assay. This factor, termed epitaxin, was purified to homogeneity by ammonium sulfate precipitation, hydrophobic interaction chromatography on phenyl-Sepharose, and a series of reverse phase high performance liquid chromatography. Under a nonreducing condition, purified epitaxin migrated as a 36-kDa band, and the biological activity was recovered from the area in the gel coinciding with this band. Purified epitaxin stimulates the motility of HepG2 cells in the concentrations above 1 ng/ml with half-maximal activity at 4.2 ng/ml, and its mode of action is mainly chemotactic. Epitaxin slightly stimulates DNA synthesis of HepG2 cells, while scatter factor/hepatocyte growth factor which also stimulates the motility of HepG2 cells showed a growth-inhibitory effect. Epitaxin increases the motility of a wide variety of epithelially derived tumor cell lines, but none of the tested fibroblast lines responded to epitaxin. These results define epitaxin as a novel fibroblast-derived factor that affects the migration, and possibly the invasion, of epithelially derived tumor cells.
我们已经在人成纤维细胞的条件培养基中鉴定出一种运动因子,该因子在Boyden小室试验中可刺激HepG2细胞的迁移。这种因子被称为上皮趋化素,通过硫酸铵沉淀、苯基琼脂糖凝胶上的疏水相互作用色谱以及一系列反相高效液相色谱纯化至同质。在非还原条件下,纯化的上皮趋化素以36 kDa条带迁移,并且从凝胶中与该条带一致的区域回收了生物活性。纯化的上皮趋化素在浓度高于1 ng/ml时刺激HepG2细胞的运动,在4.2 ng/ml时具有半数最大活性,其作用方式主要是趋化性的。上皮趋化素轻微刺激HepG2细胞的DNA合成,而同样刺激HepG2细胞运动的分散因子/肝细胞生长因子则显示出生长抑制作用。上皮趋化素增加了多种上皮来源的肿瘤细胞系的运动性,但所测试的成纤维细胞系均未对上皮趋化素产生反应。这些结果将上皮趋化素定义为一种新型的成纤维细胞衍生因子,它影响上皮来源的肿瘤细胞的迁移,可能还影响其侵袭。